Antimicrobial stewardship in the intensive care unit: evolving challenges and data science opportunities

Unravelling and customizing phage lysin specificity under therapeutic conditions

Advancing beta-lactam antibiotic therapeutic drug monitoring from (pre-)analytical optimisation to automated 24/7 bio-analysis

PK/PD-based dose optimisation of antibiotics in clinical practice

Research into the role of HNF4a and heptocyte de-differentiation in human sepsis.

TDM of antibiotics in ICU patients: added value of unbound and oral fluid concentrations

The Design of Predictive and Uncertainty-Calibrated Treatment Models for the Intensive Care Unit

A pHase III cluster randomIsed controlled, cross-over, non-inferiority Trial of a short course, High dose Antibiotics vs standaRd dose and Duration in critically ill patients (HIT-HARD)

HEROI2C: Hybrid machinE leaRning for Improved Infection management in Critically ill patients

Hybrid AI and Uncertainty Quantification for Trustworthy Time-to-Event Predictions

STOP_SEPSIS: investigation into a new concept of sepsis, the greatest unmet medical need of our times.

Strategic Institutional Partnership University of Queensland

Patient-tailored antibiotic therapy for severe infections in the ICU